References

1. Group MS. Allergic rhinitis and impairment issues in schoolchildren: a consensus report. Curr Med Res Opin 2004;20(12):1937-52.
2. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108(1):S45-53.
3. Finn AF, Kaplan AP, Fretwell R, Qu R, Long J. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1-78.
4. Gimenez-Arnau A, Izquierdo I, Maurer M. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo-controlled treatment with rupatadine 10 and 20 mg. J Eur Acad Dermatol Venereol 2009;23(9):1088-91.
5. Godse KV, Nadkarni NJ, Jani G, Ghate S. Fexofenadine in higher doses in chronic spontaneous urticaria. Indian Dermatol 2010;1(1):45.
6. Keam SJ, Plosker GL. Rupatadine: a review of its use in the management of allergic disorders. Drugs 2007;67:457-74.
7. Metz M, Scholz E, Ferrán M, Zquierdo I, Giménez-Arnau A, Maurer M. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann Allergy Asthma Immunol 2010;104(1):86-92. cold urticaria. Ann Allergy Asthma Immunol 2010;104(1):86-92.
8. Nelson HS, Reynolds R, Mason J. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2000;84(5):517-22.
9. Paul E, Berth-Jones J, Ortonne J, Stern M. Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: A placebo-controlled, parallel-group, dose-ranging study. J Dermatol Treat 1998;101:410–20.

Home page

References

1. Group MS. Allergic rhinitis and impairment issues in schoolchildren: a consensus report. Curr Med Res Opin 2004;20(12):1937-52.
2. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108(1):S45-53.
3. Finn AF, Kaplan AP, Fretwell R, Qu R, Long J. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1-78.
4. Gimenez-Arnau A, Izquierdo I, Maurer M. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo-controlled treatment with rupatadine 10 and 20 mg. J Eur Acad Dermatol Venereol 2009;23(9):1088-91.
5. Godse KV, Nadkarni NJ, Jani G, Ghate S. Fexofenadine in higher doses in chronic spontaneous urticaria. Indian Dermatol 2010;1(1):45.
6. Keam SJ, Plosker GL. Rupatadine: a review of its use in the management of allergic disorders. Drugs 2007;67:457-74.
7. Metz M, Scholz E, Ferrán M, Zquierdo I, Giménez-Arnau A, Maurer M. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann Allergy Asthma Immunol 2010;104(1):86-92.
8. Nelson HS, Reynolds R, Mason J. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2000;84(5):517-22.
9. Paul E, Berth-Jones J, Ortonne J, Stern M. Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: A placebo-controlled, parallel-group, dose-ranging study. J Dermatol Treat 1998;101:410–20.
10. Telfast 120 Tablets Professional Information, 5 October 2022.
11. Telfast 180 Tablets Professional Information, 11 May 2022.
12. Telfast Suspension Professional Information, 30 November 2022.

Product

References

1. Group MS. Allergic rhinitis and impairment issues in schoolchildren: a consensus report. Curr Med Res Opin 2004;20(12):1937-52.
2. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108(1):S45-53.
3. Finn AF, Kaplan AP, Fretwell R, Qu R, Long J. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1-78.
4. Gimenez-Arnau A, Izquierdo I, Maurer M. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo-controlled treatment with rupatadine 10 and 20 mg. J Eur Acad Dermatol Venereol 2009;23(9):1088-91.
5. Godse KV, Nadkarni NJ, Jani G, Ghate S. Fexofenadine in higher doses in chronic spontaneous urticaria. Indian Dermatol 2010;1(1):45.
6. Keam SJ, Plosker GL. Rupatadine: a review of its use in the management of allergic disorders. Drugs 2007;67:457-74.
7. Metz M, Scholz E, Ferrán M, Zquierdo I, Giménez-Arnau A, Maurer M. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann Allergy Asthma Immunol 2010;104(1):86-92.
8. Nelson HS, Reynolds R, Mason J. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2000;84(5):517-22.
9. Paul E, Berth-Jones J, Ortonne J, Stern M. Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: A placebo-controlled, parallel-group, dose-ranging study. J Dermatol Treat 1998;101:410–20.
10. Telfast 120 Tablets Professional Information, 5 October 2022.
11. Telfast 180 Tablets Professional Information, 11 May 2022.
12. Telfast Suspension Professional Information, 30 November 2022.

Telfast^® 120 mg

References

1. Group MS. Allergic rhinitis and impairment issues in schoolchildren: a consensus report. Curr Med Res Opin 2004;20(12):1937-52.
2. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108(1):S45-53.
3. Finn AF, Kaplan AP, Fretwell R, Qu R, Long J. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1-78.
4. Gimenez-Arnau A, Izquierdo I, Maurer M. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo-controlled treatment with rupatadine 10 and 20 mg. J Eur Acad Dermatol Venereol 2009;23(9):1088-91.
5. Godse KV, Nadkarni NJ, Jani G, Ghate S. Fexofenadine in higher doses in chronic spontaneous urticaria. Indian Dermatol 2010;1(1):45.
6. Keam SJ, Plosker GL. Rupatadine: a review of its use in the management of allergic disorders. Drugs 2007;67:457-74.
7. Metz M, Scholz E, Ferrán M, Zquierdo I, Giménez-Arnau A, Maurer M. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann Allergy Asthma Immunol 2010;104(1):86-92.
8. Nelson HS, Reynolds R, Mason J. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2000;84(5):517-22.
9. Paul E, Berth-Jones J, Ortonne J, Stern M. Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: A placebo-controlled, parallel-group, dose-ranging study. J Dermatol Treat 1998;101:410–20.
10. Telfast 120 Tablets Professional Information, 5 October 2022.
11. Emeryk A, Emeryk-Maksymiuk J, Janeczek K. New guidelines for the treatment of seasonal allergic rhinitis. Postepy Dermatol Alergol 2019;36(3):255-60

Telfast^® 180 mg

References

1. Group MS. Allergic rhinitis and impairment issues in schoolchildren: a consensus report. Curr Med Res Opin 2004;20(12):1937-52.
2. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108(1):S45-53.
3. Finn AF, Kaplan AP, Fretwell R, Qu R, Long J. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1-78.
4. Gimenez-Arnau A, Izquierdo I, Maurer M. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo-controlled treatment with rupatadine 10 and 20 mg. J Eur Acad Dermatol Venereol 2009;23(9):1088-91.
5. Godse KV, Nadkarni NJ, Jani G, Ghate S. Fexofenadine in higher doses in chronic spontaneous urticaria. Indian Dermatol 2010;1(1):45.
6. Keam SJ, Plosker GL. Rupatadine: a review of its use in the management of allergic disorders. Drugs 2007;67:457-74.
7. Metz M, Scholz E, Ferrán M, Zquierdo I, Giménez-Arnau A, Maurer M. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann Allergy Asthma Immunol 2010;104(1):86-92.
8. Nelson HS, Reynolds R, Mason J. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2000;84(5):517-22.
9. Paul E, Berth-Jones J, Ortonne J, Stern M. Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: A placebo-controlled, parallel-group, dose-ranging study. J Dermatol Treat 1998;101:410–20.
10. Telfast 180 Tablets Professional Information, 11 May 2022.
11. Emeryk A, Emeryk-Maksymiuk J, Janeczek K. New guidelines for the treatment of seasonal allergic rhinitis. Postepy Dermatol Alergol 2019;36(3):255-60.

Telfast^® Suspension

References

1. Group MS. Allergic rhinitis and impairment issues in schoolchildren: a consensus report. Curr Med Res Opin 2004;20(12):1937-52.
2. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108(1):S45-53.
3. Finn AF, Kaplan AP, Fretwell R, Qu R, Long J. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1-78.
4. Gimenez-Arnau A, Izquierdo I, Maurer M. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo-controlled treatment with rupatadine 10 and 20 mg. J Eur Acad Dermatol Venereol 2009;23(9):1088-91.
5. Godse KV, Nadkarni NJ, Jani G, Ghate S. Fexofenadine in higher doses in chronic spontaneous urticaria. Indian Dermatol 2010;1(1):45.
6. Keam SJ, Plosker GL. Rupatadine: a review of its use in the management of allergic disorders. Drugs 2007;67:457-74.
7. Metz M, Scholz E, Ferrán M, Zquierdo I, Giménez-Arnau A, Maurer M. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann Allergy Asthma Immunol 2010;104(1):86-92.
8. Nelson HS, Reynolds R, Mason J. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2000;84(5):517-22.
9. Paul E, Berth-Jones J, Ortonne J, Stern M. Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: A placebo-controlled, parallel-group, dose-ranging study. J Dermatol Treat 1998;101:410–20.
10. Telfast Suspension Professional Information, 30 November 2022.
11. Emeryk A, Emeryk-Maksymiuk J, Janeczek K. New guidelines for the treatment of seasonal allergic rhinitis. Postepy Dermatol Alergol 2019;36(3):255-60.

About Allergies

References

1. Ryan D, Yusuf O, Ostergaard MS, Roman-Rodriguez M. Supporting Statement by the International Primary Care Respiratory Group. In: R, Canonica GW, Holgate ST, Lockey RF, Blaiss MS (Eds.). World Allergy Organization (WAO) White Book on Allergy: Update 2013.
2. Asthma and Allergy Foundation of America. Allergy Symptoms [online]. 2022, Aug 08 [cited 2023, Nov 07]. Retrieved from: URL: https://aafa.org/allergies/allergy-symptoms/.
3. Smallwood JC. Allergies [online]. 2016, Oct [cited 2023, Nov 07]. Retrieved from: URL: https://kidshealth.org/en/teens/allergies.html?ref=search.
4. Asthma and Allergy Foundation of America. Allergy Treatments [online]. 2018, Mar [cited 2023, Nov 07]. Retrieved from: URL: https://aafa.org/allergies/allergy-treatments/.
5. Australasian Society of Clinical Immunology and Allergy. Common Myths About Allergy and Asthma Exposed [online. 2019, Apr [cited 2023, Nov 07]. Retrieved from: URL:
https://www.allergy.org.au/patients/about-allergy/common-myths-about-allergy-and-asthma-exposed.
6. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108(1):S45-53.
7. Group MS. Allergic rhinitis and impairment issues in schoolchildren: a consensus report. Curr Med Res Opin 2004;20(12):1937-52.
8. Finn AF, Kaplan AP, Fretwell R, Qu R, Long J. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1-78.
9. Gimenez-Arnau A, Izquierdo I, Maurer M. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo-controlled treatment with rupatadine 10 and 20 mg. J Eur Acad Dermatol Venereol 2009;23(9):1088-91.
10. Godse KV, Nadkarni NJ, Jani G, Ghate S. Fexofenadine in higher doses in chronic spontaneous urticaria. Indian Dermatol 2010;1(1):45.
11. Keam SJ, Plosker GL. Rupatadine: a review of its use in the management of allergic disorders. Drugs 2007;67:457-74.
12. Metz M, Scholz E, Ferrán M, Zquierdo I, Giménez-Arnau A, Maurer M. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann Allergy Asthma Immunol 2010;104(1):86-92.
13. Nelson HS, Reynolds R, Mason J. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2000;84(5):517-22.
14. Paul E, Berth-Jones J, Ortonne J, Stern M. Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: A placebo-controlled, parallel-group, dose-ranging study. J Dermatol Treat 1998;101:410–20.

Allergic Rhinitis

References

1. American Academy of Allergy Asthma and Immunology. Allergy Statistics [online]. [cited 2023, Nov 08]. Retrieved from: URL: https://www.aaaai.org/about/news/for-media/allergy-statistics.
2. American College of Allergy, Asthma and Immunology. Hay Fever [online]. 2020, Jun 17 [cited2023, Nov 08]. Retrieved from: URL: https://acaai.org/allergies/allergic-conditions/hay-fever/.
3. American College of Allergy, Asthma and Immunology. Cough [online]. [cited 2023, Nov 08]. Retrieved from: URL: https://acaai.org/allergies/symptoms/cough/.
4. American Academy of Allergy Asthma and Immunology. Rhinitis (Hay Fever) [online]. 2023, Aug 28 [cited 2023, Nov 08]. Retrieved from: URL:
https://www.aaaai.org/tools-for-the-public/conditions-library/allergies/rhinitis-(hay-fever).
5. Ferreira LK, Ferreira LA, Monteiro TM, Bezerra GC, Bernardo LR, Piuvezam MR. Combined allergic rhinitis and asthma syndrome (CARAS). Int Immunopharmacol 2019;74:105718.
6. Asthma and Allergy Foundation of America. Allergy Treatments [online]. 2018, Mar [cited 2023, Nov 07]. Retrieved from: URL: https://aafa.org/allergies/allergy-treatments/.
7. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108(1):S45-53.

Urticaria

References

1. Australasian Society of Clinical Immunology and Allergy. Hives (Urticaria) [online]. 2021, Mar [cited 2023, Nov 08]. Retrieved from: URL: https://www.allergy.org.au/patients/skin-allergy/urticaria-hives.
2. Schaefer P. Acute and chronic urticaria: evaluation and treatment. Am Fam Phys 2017;95(11):717-24.
3. Asthma and Allergy Foundation of America. Allergy Symptoms [online]. 2022, Aug 08 [cited 2023, Nov 07]. Retrieved from: URL: https://aafa.org/allergies/allergy-symptoms/.
4. American College of Allergy, Asthma and Immunology. Hives [online]. 2018, Jun 11 [cited 2023, Nov 08]. Retrieved from: URL: https://acaai.org/allergies/allergic-conditions/skin-allergy/hives/.
5. Asthma and Allergy Foundation of America. Allergy Treatments [online]. 2018, Mar [cited 2023, Nov 07]. Retrieved from: URL: https://aafa.org/allergies/allergy-treatments/.
6. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108(1):S45-53.

Allergy vs Cold

References

1. Mayo Clinic. Cold or allergy: Which is it? [online]. 2022, Feb 17 [cited 2023, Nov 08]. Retrieved from: URL: https://www.mayoclinic.org/diseases-conditions/common-cold/expert-answers/common-cold/faq-20057857.
2. Faris S. Is It Allergies or a Cold? [online]. 2021, Dec 23 [cited 2023, Nov 08]. Retrieved from: URL: https://www.healthline.com/health/allergies/allergies-or-cold.
3. Asthma and Allergy Foundation of America. Allergy Treatments [online]. 2018, Mar [cited 2023, Nov 07]. Retrieved from: URL: https://aafa.org/allergies/allergy-treatments/.
4. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108(1):S45-53.

Allergic Rhinitis vs Sinusitis

References

1. Cherney K. Allergies or Sinus Infection: How to Tell the Difference [Internet]. Healthline. 2018 [cited 2023 Dec 21]. Available from: https://www.healthline.com/health/allergies-or-sinus-infection.
2. Asthma and Allergy Foundation of America. Allergy Treatments [online]. 2018, Mar [cited 2023, Nov 07]. Retrieved from: URL: https://aafa.org/allergies/allergy-treatments/.
3. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108(1):S45-53.

Allergies in Children

References

1. Iannelli V. A Parent’s Guide to Allergies in Children [online]. 2023, Jan 18 [cited 2023, Nov 08]. Retrieved from: URL: https://www.verywellfamily.com/allergy-symptoms-and-treatments-2633158.
2. American College of Allergy, Asthma and Immunology. Who Gets Allergies?: Children [online]. [cited 2023, Nov 08]. Retrieved from: URL: https://acaai.org/allergies/allergies-101/who-gets-allergies/children/.
3. Asthma and Allergy Foundation of America. Allergy Treatments [online]. 2018, Mar [cited 2023, Nov 07]. Retrieved from: URL: https://aafa.org/allergies/allergy-treatments/.
4. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108(1):S45-53.

Antihistamines

References

1. Simons FE, Simons KJ. Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol 2011;128(6):1139-50.
2. Cleveland Clinic. Antihistamines [online]. 2020, Jul 13 [cited 2023, Nov 08]. Retrieved from: URL: https://my.clevelandclinic.org/health/drugs/21223-antihistamines.
3. Blaiss M. Allergic rhinitis and impairment issues in schoolchildren: a consensus report. Current Medical Research and Opinion. 2004;20(12):1937–52.
4. Asthma and Allergy Foundation of America. Allergy Treatments [online]. 2018, Mar [cited 2023, Nov 07]. Retrieved from: URL: https://aafa.org/allergies/allergy-treatments/.
5. Telfast 120 Tablets Professional Information, 5 October 2022.
6. Telfast 180 Tablets Professional Information, 11 May 2022.
7. Telfast Suspension Professional Information, 30 November 2022.
8. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108(1):S45-53.

FAQs

References

1. Simons FE, Simons KJ. Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol 2011;128(6):1139-50.
2. Cleveland Clinic. Antihistamines [online]. 2020, Jul 13 [cited 2023, Nov 08]. Retrieved from: URL: https://my.clevelandclinic.org/health/drugs/21223-antihistamines.
3. Blaiss M. Allergic rhinitis and impairment issues in schoolchildren: a consensus report. Current Medical Research and Opinion. 2004;20(12):1937–52.
4. Telfast Suspension Professional Information, 30 November 2022.
5. Telfast 120 Tablets Professional Information, 5 October 2022.
6. Telfast 180 Tablets Professional Information, 11 May 2022.
7. Cherney K. Allergies or Sinus Infection: How to Tell the Difference [Internet]. Healthline. 2018 [cited 2023 Dec 21]. Available from: https://www.healthline.com/health/allergies-or-sinus-infection.
8. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108(1):S45-53.
9. Group MS. Allergic rhinitis and impairment issues in schoolchildren: a consensus report. Curr Med Res Opin 2004;20(12):1937-52.
10. Finn AF, Kaplan AP, Fretwell R, Qu R, Long J. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1-78.
11. Gimenez-Arnau A, Izquierdo I, Maurer M. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo-controlled treatment with rupatadine 10 and 20 mg. J Eur Acad Dermatol Venereol 2009;23(9):1088-91.
12. Godse KV, Nadkarni NJ, Jani G, Ghate S. Fexofenadine in higher doses in chronic spontaneous urticaria. Indian Dermatol 2010;1(1):45.
13. Keam SJ, Plosker GL. Rupatadine: a review of its use in the management of allergic disorders. Drugs 2007;67:457-74.
14. Metz M, Scholz E, Ferrán M, Zquierdo I, Giménez-Arnau A, Maurer M. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann Allergy Asthma Immunol 2010;104(1):86-92.
15. Nelson HS, Reynolds R, Mason J. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2000;84(5):517-22.
16. Paul E, Berth-Jones J, Ortonne J, Stern M. Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: A placebo-controlled, parallel-group, dose-ranging study. J Dermatol Treat 1998;101:410–20.